Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Erratum to 2025 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Surgical management of acute myocardial infarction and associated complications: The Journal of Thoracic and Cardiovascular Surgery, Volume 170, Issue 5, 2025, Pages 1327-1344.

The Journal of thoracic and cardiovascular surgery·2026

Same author

Predictive Value of the Pulmonary Artery Pulsatility Index in Pulmonary Arterial Hypertension: REVEAL Analysis.

Cardiology research·2026

Same author

Universal Pulmonary Resistance-Compliance Relationship: And Why It Matters?

Circulation. Heart failure·2026

Same author

STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathy.

Cardiovascular research·2026

Same author

Prevention and Management of Acute Limb Ischemia when Using Temporary Mechanical Circulatory Support Devices.

Interventional cardiology clinics·2026

Same author

Clinical Characteristics and Outcomes in Intra-aortic Balloon Pump-Supported Cardiogenic Shock Among Patients Transferred to Tertiary Care Centers.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026

Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026

Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026

Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026

Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026

Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 5, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Temporary mechanical circulatory support devices: updates from recent studies.

Jeffrey A Marbach^1,2, Haval Chweich¹, Satoshi Miyashita^2,3

¹Division of Pulmonary, Critical Care and Sleep Medicine.

Current Opinion in Cardiology

|May 15, 2021

Summary

This summary is machine-generated.

Short-term mechanical circulatory support (MCS) devices show promise in treating cardiogenic shock and supporting patients in critical cardiac conditions. Emerging data highlight their utility in various clinical scenarios, despite limited randomized trials.

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Nov 5, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

Cardiology
Critical Care Medicine
Biomedical Engineering

Background:

Mechanical circulatory support (MCS) is crucial for managing cardiogenic shock (CS).
Temporary MCS devices are increasingly utilized in diverse clinical settings.
These settings include pre-cardiac surgery, high-risk percutaneous coronary intervention, and as a bridge to cardiac transplantation.

Purpose of the Study:

To review recent literature on the evolving role of temporary MCS devices.
To provide insights into current challenges and future research directions in MCS.

Main Methods:

Review of recent observational data and clinical trials.
Analysis of outcomes in patients receiving temporary MCS.
Evaluation of specific devices like intra-aortic balloon pumps, Impella, and extracorporeal membrane oxygenation (ECMO).

Main Results:

Observational data suggest preoperative intra-aortic balloon pump utility in high-risk coronary artery bypass grafting patients.
Impella shows promise in early MCS strategies for CS, bridging to transplantation, and left ventricular unloading during ECMO.
A randomized trial indicated improved survival with ECMO-facilitated resuscitation for out-of-hospital cardiac arrest.

Conclusions:

Observational data consistently support the use of temporary MCS devices across various clinical applications.
Randomized trial data remain limited but are growing.
Further research is needed to solidify the role of temporary MCS in critical care cardiology.